SHENZHEN, China--(BUSINESS WIRE)--Tongjitang Chinese Medicines Company (the “Company” or “Tongjitang”) (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that it will hold its annual general meeting of shareholders for the fiscal year ended December 31, 2009 at the Company’s executive office on 5th Floor, Block B, Nanshan Medical Device Park, 1019 Nanhai Avenue, Nanshan District, Shenzhen, 518067 Guangdong Province, People’s Republic of China on December 23, 2009 at 11 a.m. (local time). The meeting is being held to provide a forum for the Company’s chairman of the board of directors and chief executive officer to report on company affairs, and for management and holders of the Company’s ordinary shares or ADSs to discuss the progress and direction of the Company’s business. No proposal is expected to be submitted to the shareholders for voting at the meeting.
